Last Updated： Aggregation Period:Feb 04, 2026～Mar 03, 2026
This ranking is based on the number of page views on our site.
Last Updated： Aggregation Period:Feb 04, 2026～Mar 03, 2026
This ranking is based on the number of page views on our site.
Last Updated： Aggregation Period:Feb 04, 2026～Mar 03, 2026
This ranking is based on the number of page views on our site.
121～142 item / All 142 items
【様々な化学反応に対応！】独自開発したマイクロ流路形成技術を利用した新しい原理の反応装置、強制超薄膜型マイクロリアクターです。
ULREAは、回転ディスクと固定ディスクの間に形成した強制薄膜(マイクロ流路)を反応場としたリアクターです。 晶析・還元反応はもとより、全ての化学反応に適用できます。 シングルナノ粒子からマイクロ粒子まで容易に粒子径のコントロールが可能です。 【特徴】 ○反応流路幅：1～30μm ○詰まり （結晶、気泡）：自己排出能があり、閉塞がない ○リーク：圧力損失が小さい ○反応時間制御：反応条件、装置運転条件で 自由に制御可能 ○スケールアップ：大量生産に容易に対応可能 ○エネルギーコスト：生産に必要なエネルギーが小さい ●詳しくはお問い合わせ、またはカタログをダウンロードしてください。
The batch reaction of organic synthesis, which used to take several days, can now be shortened to just a few hours.
At Emmaus Kyoto Co., Ltd., we have developed a novel organic polymer porous body (polymer monolith) with a co-continuous structure based on epoxy resin, supported by metal nanoparticle catalysts. This high-performance monolith reactor enables the synthesis of target compounds in a short time and with high efficiency through flow organic synthesis. By applying this monolith reactor to an environmentally friendly synthesis-oriented flow organic synthesis system, we can greatly expect its application in the production of electronic functional materials, pesticides, and pharmaceutical intermediates through the creation of a new compound library. 【Features】 - Monolith reactor derived from resin - Reduces synthesis time of compounds by up to about 1/10 - Strong against alkaline solutions - Usable with standard HPLC For more details, please contact us or download the catalog.
![[Research Material] Global Market for Bioremediation Technology](https://image.mono.ipros.com/public/product/image/41e/2001467384/IPROS17428692900926730818.jpeg?w=280&h=280)
World Market for Bioremediation Technologies: Bioreactors, Biostimulation, Bioaugmentation, Fungal Remediation ...
This research report (Global Bioremediation Technology Market) investigates and analyzes the current state of the global bioremediation technology market and its outlook for the next five years. It includes information on the overview of the global bioremediation technology market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the bioremediation technology market include bioreactors, biostimulation, bioaugmentation, fungal remediation, phytoremediation, and terrestrial treatment, while the segments by application focus on hospitals, specialized clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of bioremediation technology. It also includes the market share of major companies in the bioremediation technology sector, product and business overviews, and sales performance.
![[Research Material] Global Market for Single-Use Technologies in Biopharmaceuticals](https://image.mono.ipros.com/public/product/image/fcb/2001476598/IPROS43858830858997914855.jpeg?w=280&h=280)
Global Market for Single-Use Technologies in Biopharmaceuticals: Disposable Bioreactors, Membrane Adsorbers, Media Bags, Bioprocess ...
This research report (Global Single Use Technologies for Biopharmaceuticals) investigates and analyzes the current state and future outlook of the global market for single-use technologies in biopharmaceuticals over the next five years. It includes information on the overview of the global market for single-use technologies in biopharmaceuticals, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for single-use technologies in biopharmaceuticals by type include disposable bioreactors, membrane adsorbers, media bags, bioprocess containers, and others, while the segments by application focus on contract manufacturing organizations and biopharmaceutical manufacturers. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for single-use technologies in biopharmaceuticals. The report also includes the market share of major companies in single-use technologies for biopharmaceuticals, product and business overviews, and sales performance.
![[Market Report] Large and Small Scale Bioprocessing Market](https://image.mono.ipros.com/public/product/image/86a/2001086775/IPROS72586195084378787572.jpeg?w=280&h=280)
The global large-scale and small-scale bioprocessing market is expected to revolutionize biomanufacturing and reach 185.5 billion USD by 2031.
The global large-scale and small-scale bioprocess market is driving innovation in biomanufacturing and paving the way for groundbreaking advancements in biopharmaceutical production. According to recent market reports, the global large-scale and small-scale bioprocess market achieved approximately $57.08 billion in revenue in 2022 and is estimated to reach $185.5 billion by 2031. This remarkable growth trajectory is expected to see an extraordinary compound annual growth rate (CAGR) of 14% from 2023 to 2031. Large-scale bioprocesses represent the pinnacle of industrial-scale bioproduct and biopharmaceutical production, addressing the needs of diverse patient populations. Companies operate large bioreactors with capacities ranging from thousands to tens of thousands of liters, prioritizing efficiency, cost-effectiveness, and automation. Large-scale bioprocesses facilitate the mass production of established biopharmaceuticals, such as monoclonal antibodies and vaccine antibodies, which have a widespread impact globally. For application details, please check the [PDF download] button or apply directly through the relevant links.
It is a reactor that reproduces the fermentation process of a plant in the laboratory.
There is a supply port for replenishing raw materials and a discharge port with a ball valve for discharging slurry, allowing for continuous experiments. The stirring device can set the rotation speed and direction. The pipe connection uses a tri-clamp method, making it easy to connect and disconnect.
Covers basic knowledge, organic synthesis, polymer synthesis, research trends, future developments, and more!
【Venue】 Kawasaki City Industrial Promotion Hall, 10th Floor, Room 2【Kanagawa, Kawasaki】 【Date and Time】 March 24, 2015 (Tuesday) 13:30-16:30 【Instructor】 Aichiro Nagaki, Lecturer, Graduate School of Engineering, Kyoto University
It is possible to change the shape of particles and react at temperatures higher than the boiling point. There is no concern about flow path blockage. We are currently presenting examples of iron oxide nanoparticle synthesis.
The "ULREA Series" is a microreactor that can continuously synthesize nanoparticles such as metals and organic pigments. By using a unique method that employs a gap of 1 to 30 μm between two disks as the reaction field, it contributes to shortening reaction times and improving yields, while also solving the problem of flow path blockage. By controlling the pH during the reaction, it is possible to change the particle shape, and the pressure control in the reaction area allows for reactions to be conducted at temperatures higher than the boiling point. 【Features】 ■ Easily produces fine particles of metals, alloys, oxides, composite oxides, organic pigments, pharmaceuticals (active ingredients and intermediates), core-shell structures, and more. ■ Excellent self-discharging properties, eliminating concerns about blockage due to the generation of products or bubbles. ■ Available in three models: standard, tabletop, and mass production equipment. ★ In addition to the catalog, we are currently offering materials that introduce examples of fine particle synthesis of iron oxide. You can view them via "PDF Download."
Accelerate CO2 reduction and SDGs with continuous flow devices! Support experiments with rental labs. We assist in solving challenges with safe, secure, and highly efficient continuous flow.
Experiments on chemical processes necessary for the development of pharmaceuticals, such as synthesis, mixing, extraction, separation, recrystallization, hydrogen reduction, and cleaning, can be conducted in a continuous flow system. Precise control of temperature, flow rate, and pressure contributes to safe operation and accelerates research and development. Materials can be changed to suit chemical resistance (SUS316L, nickel alloy, PTFE, glass, etc.). We support the possibility of continuous production through the design and manufacture of flow reactor systems. 【Products Offered】 ■ Microreactors (precise mixing, ultrafine particles) ■ Integrated microreactors (with scale-up options) ■ Micro-scale CSTR (hydrogen reduction, recrystallization) ■ Mixer settlers (extraction/separation, cleaning, continuous flow of separating funnels) ■ Microwave irradiation flow reactors (reducing reaction time through internal heating) 【Available Equipment for Rental Lab】 ○ Analyzers (liquid chromatography (HPLC), gas chromatography, ReactIR, microscope, etc.) ○ Various pumps (syringe, diaphragm, tube, mono, etc.) *For more details, please download the PDF or feel free to contact us.
Industry-standard high-throughput bioreactor system optimized for process characteristic analysis.
The Ambr 250 High Throughput Generation 2 is a multi-parallel bioreactor system that accelerates process development and characterization analysis schedules to achieve cost reduction. Its fully continuous gas supply system realizes similarity with large-scale bioreactors and optimizes the scale-down model. Through the integration of analysis options such as the capacitance-based BioPAT Viamass, it supports extensive feedback control.
![[Research Material] World Market for Cell Culture Equipment](https://image.mono.ipros.com/public/product/image/423/2000846064/IPROS15664060158105654377.jpeg?w=280&h=280)
Global Market for Cell Culture Equipment: Cell Culture Vessels, Bioreactors, Biosafety Cabinets, Pharmaceutical and Biotechnology Industries ...
This research report (Global Cell Culture Instrument Market) investigates and analyzes the current state and outlook for the global cell culture instrument market over the next five years. It includes information on the overview of the global cell culture instrument market, trends of major companies (sales, selling prices, market share), market size by segment, market size by key regions, and distribution channel analysis. The market segments by type include cell culture containers, bioreactors, and biosafety cabinets, while the segments by application focus on the pharmaceutical and biotechnology industries, academic institutions, and research centers. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for cell culture instruments. It also includes the market share of major companies in the cell culture instrument sector, product and business overviews, and sales performance.
![[Research Material] Global Market for Cell Therapy Bioprocesses](https://image.mono.ipros.com/public/product/image/5c1/2001467243/IPROS87173721957081752429.jpeg?w=280&h=280)
Global Market for Cell Therapy Bioprocesses: Immune Cells, Human Embryonic Stem Cells, Pluripotent Stem Cells, Hematopoietic Stem Cells, Cardiovascular Diseases (CVD), Tumors ...
This research report (Global Cell Therapy Bioprocessing Market) investigates and analyzes the current state and future outlook of the global cell therapy bioprocessing market over the next five years. It includes information on the overview of the global cell therapy bioprocessing market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the cell therapy bioprocessing market focus on immune cells, human embryonic stem cells, pluripotent stem cells, and hematopoietic stem cells, while the segments by application target cardiovascular diseases (CVD), oncology, wound healing, orthopedics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of cell therapy bioprocessing. It also includes the market share of major companies in the cell therapy bioprocessing market, product and business overviews, and sales performance.
